GARRETT FREEMAN: Open Payments
NPI 1598846719 · NEWNAN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$715 in 29 payments from 10 companies in 2025. Trend: 2023 $374 · 2024 $908 · 2025 $715
Food & beverage: $715
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $373 |
| GENZYME CORPORATION | 2 | $96 |
| Arcutis Biotherapeutics, Inc. | 3 | $53 |
| Lilly USA, LLC | 2 | $41 |
| Galderma Laboratories, L.P. | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| Amgen Inc. | 1 | $26 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $20 |
| Janssen Biotech, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $17 |
Products named: SKYRIZI, RINVOQ, DUPIXENT, Zoryve, TALTZ, NEMLUVIO, LIBTAYO, Otezla.
Industry payments across GA — which companies pay providers there.
